BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180413
DTSTAMP:20260515T052604
CREATED:20180131T133231Z
LAST-MODIFIED:20180201T152133Z
UID:8955-1523404800-1523577599@www.pharmajournalist.com
SUMMARY:Asthma & COPD
DESCRIPTION:SMi is excited to announce the latest event in their Asthma & COPD series\, which returns to London on the 11th-12th April 2018. \nWith asthma and chronic obstructive pulmonary disorder (COPD) affecting about 500 million people worldwide\, opportunities in drug development are vast and reducing serious attacks by improving adherence could save $19 billion a year in U.S. healthcare costs* http://reut.rs/2xqyBjZ \nRecent advances in injectable biologics and smart medical devices as led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars\, the need for guideline updates from regulators has increased and continues to be modified. \nJoin us as we discuss current clinical trials and the innovative digital technology being used to improve clinical adherence. Leading industry experts will be looking at the use of ‘real world data’ human factors in the design of medical devices and triple combination treatments on the market. We will also be looking at asthma and COPD Phenotyping and biomarker application and differences between in the EU and US for the approval of biologics. We will be exploring the complexities of dry powder formulation and helping you determine clinical efficacy and endpoints. \nTo learn more about this event\, and to register online\, visit www.asthma-copd.co.uk/pharmajourno
URL:https://www.pharmajournalist.com/event/asthma-copd/
LOCATION:Copthorne Tara Hotel\, London
ORGANIZER;CN="SMi Group Ltd":MAILTO:acaddick@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180413
DTSTAMP:20260515T052604
CREATED:20171128T075734Z
LAST-MODIFIED:20171128T075957Z
UID:4686-1523404800-1523577599@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes East Coast
DESCRIPTION:Enabling the next generation of Pre-Filled Syringes from design to manufacturing \nBuilding on the success of previous sell-out shows\, SMi Group is delighted to announce the return of the 5th annual conference and exhibition: Pre-Filled Syringes – East Coast\, taking place on April 11th – 12th 2018 in Boston\, Massachusetts\, USA. \n \nA rise in chronic diseases\, improvements in technology and a growing demand for easy to use drug administration products has in recent years\, created a booming Pre-Filled Syringes industry. \nSome notable areas of increased attention have been the broader trends for combination products and biologics\, as well as the move towards digital health and improving patient adherence due to increased self-administration figures. As well as these areas of lucrative opportunity\, there are still several ongoing challenges that the key-thought leaders are battling to overcome such as chemical compatibility\, user safety\, high-volume and highly viscous formulation\, and non-compliance. \nPre-Filled Syringes East Coast will once again play host to an international audience of drug delivery\, medical device and PFS experts to discuss emerging trends and offer innovative solutions to the challenges facing the prefilled industry\, helping attendees to secure global success for their PFS device. \nFeatured Speakers Include: \n– Dhairyamehta\, Associate Director of Device and Combination Products\, Shire\n– Stephen Barat\, Head of Pre-Clinical and Early Clinical Development\, Scynexis\n– Susan Neadle\, Head\, Combination Products Center of Excellence\, Sr. Director\, Quality Engineering & Design-to-Value\, Janssen Pharmaceuticals\n– Justin Wright\, Vice President\, Drug Delivery Innovation\, DDR&D Technology\, Eli Lilly\n– TiemingRuan\, Associate Director of Device Development\, Takeda\n– Molly Story\, Head\, Global Usability Engineering and Risk Management\, Sanofi\n– Gary Henniger\, R&D Director\, Discovery and Product Development R&D\, Teva\n– Michael Song\, Pharmaceutical Device and Digital Health\, Medimmune\n– Steve Bowman\, Device Program Lead\, Shire\n– Gary Mills\, Associate Director\, Drug Product Development\n– Kashappa Goud Desai\, Investigator\, Biopharmaceutical Product Sciences\, GlaxoSmithKline\n– Maria Linzmayer\, Associate Director\, Drug Delivery Devices\, Merck \nReasons to Attend: \n– Navigate through the regulatory landscape through guidance on compliance\n– Understand end-use interaction with delivery systems and Human Factor engineering\n– Receive insight on delivering high concentration formulations.\n– Integrate Quality-by-Design (QbD) principles for best practice solutions in developing your combination products.\n– Updates on new technologies\, including digital monitoring biomarkers from Eli Lilly; electronic enabled drug delivery devices from MedImmune; and PFS tech transfer of in-line products from Merck.\n– Hear the latest results from recent studies in chemical compatibility; comparison of COP vs glass; and container integrity.\n– Participate in our two interactive panel discussions and gain from over 5 hours of dedicated networking time. \nA snapshot of confirmed sponsors includes: Mitsubishi Gas Chemical\, Nemera\, NN\, Inc Precision Engineered Products\, SCHOTT\, Schreiner MediPharm\, Terumo Pharmaceutical Solutions\, Zeon \nFor more information or register\, visit http://www.pfsamericas.com/pjournalist \nTo get in touch\, contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-east-coast-2018/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:tarri@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180415
DTSTAMP:20260515T052604
CREATED:20171025T014409Z
LAST-MODIFIED:20180111T031457Z
UID:3596-1523404800-1523750399@www.pharmajournalist.com
SUMMARY:The Health Industry Summit(tHIS)
DESCRIPTION:The Health Industry Summit(tHIS) – EXPO and Congress is the umbrella global Pharmaceutical and Medical industry event in Asia\, the world’s fastest growing health market. It brings together CMEF\, PharmChina and API China in one place at the same time\,the only event providing complete coverage of the health industry.It enables leading academics and professionals from around the world to meet and share the latest innovation and thinking on policies & investment\, R&D\, Manufacturing & distribution\,education & hospital applications and related services for the industry. \n\nTo learn more about this event\, and to register online\, visit https://goo.gl/5qrDQX \n 
URL:https://www.pharmajournalist.com/event/health-industry-summit-this-2018/
LOCATION:National Exhibition and Convention Center (Shanghai)
ORGANIZER;CN="Reed Sinopharm Exhibitions":MAILTO:james.wang@reedsinopharm.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180409
DTEND;VALUE=DATE:20180411
DTSTAMP:20260515T052604
CREATED:20180115T131419Z
LAST-MODIFIED:20180115T131741Z
UID:7654-1523232000-1523404799@www.pharmajournalist.com
SUMMARY:Antibodies & Antibody Drug Conjugates
DESCRIPTION:SMi is proud to present their 6th annual Antibodies and Antibody Drug Conjugates conference\, being held at the Copthorne Tara Hotel\, London\, UK on the 9th – 10th April 2018.With an every-growing industry\, the market is expected to reach USD 30 Billion by 2023.www.adcsummit.com/pjl \nAntibodies and antibody drug conjugates (ADCs) have the potential to make a ground-breaking impact upon medicinal therapies\, diagnostics and characterization of diseases. There is massive potential for ADCs to be used in the development of targeted solid tumour therapies\, due to their ability to act as precisely and effectively on target antigens. \nJoin us this April 2018\, as SMi’s ADC Summit conference brings together industry experts from leading life science and pharmaceutical companies. Key topics that will be covered in the upcoming event include: fragment drug conjugates\, ADC payloads\, site-selective ADCs/ site-specific conjugation and the best linker and warhead combinations. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \nChairs for 2018: \n– MahendraDeonarain\, Chief Executive and Scientific Officer\, Antikor Biopharma\n– Rakesh Dixit\, Vice President and Global Head Biologics Safety Assessment\, Medimmune \nKey Speakers Include: \n– Robert Lyon\, Senior Director\, Seattle Genetics\n– Arnaud Tiberghien\, Scientist II\, Spirogen\n– Alison Betts\, Associate Research Fellow\, Pfizer\n– Thomas Pillow\, Senior Scientist\, Genentech\n– Andreas Pahl\, CSO\, Heidelberg Pharma\n– Carlo Boutton\, Director of Technology\, Ablynx \nSome Featured Highlights will include: \n– Learn about the implementation of superior technologies to develop more effective and efficient Antibody Drug Conjugates.\n– Discover new and novel payloads\, e.g. Antibody Targeted Amanitin Conjugates (ATACs) and minorgroove binding DNA-interactive molecules as ADC payloads\, to expand the ADC landscape.\n– Discuss the practicalities of the use of Highly Potent Active Pharmaceutical Ingredients.\n– Refine the practice of using fragment conjugates in order to develop a tailored therapy for solid tumours.\n– Design principles for maximising the drug delivery efficiency and therapeutic index. \nView the full agenda: www.adcsummit.com/pjl
URL:https://www.pharmajournalist.com/event/antibodies-antibody-drug-conjugates/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180409
DTEND;VALUE=DATE:20180411
DTSTAMP:20260515T052604
CREATED:20171109T010959Z
LAST-MODIFIED:20171109T011019Z
UID:3890-1523232000-1523404799@www.pharmajournalist.com
SUMMARY:10th annual Adaptive Designs in Clinical Trials
DESCRIPTION:Now running for 10 years\, SMi’s annual conference on Adaptive Designs in Clinical Trials will return to London on 9th and 10th April 2018. \n \nThis year’s agenda has been curated to provide you with the latest innovations\, regulatory updates\, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug\, medical device and therapy development. \nGiving you a fresh take on this vital area of biopharma\, the event will ride the wave of technology within the pharmaceutical industry\, as we consider how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously\, the event will also explore how adaptive designs are being used for the production of personalised medicines and personalised therapies. \n  \nFeatured Speakers include: \n– James Matcham\, Head of Biometrics\, Early Clinical Development\, AstraZeneca\n– Alex Sverdlov\, Director\, Statistical Scientist\, Novartis\n– Frank Fleisher\, Principal Methodology Statistician\, Boehringer-Ingelheim\n– Christine Fletcher\, Executive Director Biostatistics\, Amgen\n– Chris Harbron\, Principal Statistical Scientist\, Roche\n– Olivier Collignon\, Biostatistician\, European Medicines Agency\n– Beatrice Panico\, Medical Advisor\, MHRA\n– Corine Baayen\, Senior Biostatistician\, H.Lundbeck \nKey Highlights \n– Explore the current industry outlook and evaluate the promises and challenges of digital technology use\n– Hear exciting case studies on enrichment designs and group sequential trials\n– Discover how big pharma companies are using Platform Trials and self-adapting priors to advance their adaptive clinical trials\n– Examine the use of adaptive clinical trials are used to produce targeted therapies\n– Learn from the latest regulatory perspectives from MHRA and EMA\, including planning and assessing umbrella and basket trials \nEarly Bird: Book by Dec 15 to save £400. Book by Jan 31 to save £200. Book by 28 Feb to save £100. \nTo learn more about this event\, and to register online\, visit http://www.adaptivedesigns.co.uk/pharmajournalist
URL:https://www.pharmajournalist.com/event/10th-annual-adaptive-designs-clinical-trials/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:hdegracia@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180409
DTEND;VALUE=DATE:20180411
DTSTAMP:20260515T052604
CREATED:20171106T103751Z
LAST-MODIFIED:20171107T020509Z
UID:3819-1523232000-1523404799@www.pharmajournalist.com
SUMMARY:Digital Pharma Japan
DESCRIPTION:The inaugural Digital Pharma Japan conference will deliver a world class event for Japanese pharmaceutical and medical device executives to learn how to embed a digital ecosystem that is tailored for execution specifically in the Japanese business model. \n  \nTo learn more about this event\, and to register online\, visit http://digitalpharmaseries.com/japan
URL:https://www.pharmajournalist.com/event/digital-pharma-japan/
LOCATION:The Westin Tokyo\, 1-4-1 Mita Meguro-ku\, Tokyo\, Tokyo 153-8580\, Japan
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180327
DTEND;VALUE=DATE:20180330
DTSTAMP:20260515T052604
CREATED:20180124T050058Z
LAST-MODIFIED:20180124T050555Z
UID:8343-1522108800-1522367999@www.pharmajournalist.com
SUMMARY:CPhI South East Asia
DESCRIPTION:CPhI South East Asia is a focused trade fair for Pharma industry\, serving the highly potential South East Asia market. Covering a complete\, end-to-end Pharma manufacturing supply chain from ingredients\, machinery & technology\, packaging\, contract services\, to analytical equipment\, the event is also held concurrently with Health ingredients (Hi) South East Asia which focuses on ingredients for functional food\, nutraceutical and nutrition. \nCPhI South East Asia emphasizes on networking\, knowledge and development opportunity. Through value-packed on site activities\, attendees are able to expand their business contacts\, meet new suppliers\, explore business opportunity\, enhance their knowledge and exchange experiences. \nJoin the exhibition\, conference\, forum\, exhibitor showcase\, focus groups\, business matchings\, and more. \n \nTo learn more about this event\, and to register online\, visit www.ubm.com/sea
URL:https://www.pharmajournalist.com/event/cphi-south-east-asia/
LOCATION:Jakarta International Expo\, Kemayoran\, Jakarta\, Indonesia
ORGANIZER;CN="PT UBM Pameran Niaga Indonesia":MAILTO:maria.lioe@ubm.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180326
DTEND;VALUE=DATE:20180329
DTSTAMP:20260515T052604
CREATED:20180119T152310Z
LAST-MODIFIED:20180119T152348Z
UID:8111-1522022400-1522281599@www.pharmajournalist.com
SUMMARY:Pharma Anti-Counterfeiting & Brand Protection Summit
DESCRIPTION:More than 1 million people a year are dying from counterfeit drugs. In addition to this overwhelming social impact\, the economic effects threaten a profitable industry meant to provide life-saving drugs all over the world. Product recall costs\, lost sales and industry fines constantly plague industry operations. With the recent Drug Diversion and Counterfeit Crackdown Act of 2017 and Operation Pangea X\, awareness is at its peak and will continue to grow. It is time to join the conversation and push the issues forward at the Pharma Anti-Counterfeiting & Brand Protection Summit. Key opinion leaders will come together to help you build a more complete brand protection strategy. \n\nTo learn more about this event\, and to register online\, visit http://bit.ly/2BeKx5I
URL:https://www.pharmajournalist.com/event/pharma-anti-counterfeiting-brand-protection-summit/
LOCATION:Hilton Garden Inn Philadelphia Center City\, 1100 Arch Street\, Philadelphia\, Pennsylvania\, 19107\, United States
ORGANIZER;CN="IQPC":MAILTO:enquiryiqpc@iqpc.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180324
DTSTAMP:20260515T052604
CREATED:20171205T022232Z
LAST-MODIFIED:20180103T070336Z
UID:4992-1521590400-1521849599@www.pharmajournalist.com
SUMMARY:ePharma
DESCRIPTION:Join more than 500 digital pharma marketers\, technologists\, and digital agencies at ePharma 2018 to discuss the ongoing digital evolution of marketing practices in pharma and biotech and the continual digitization of the patient and HCP journeys. \nePharma is a long-standing platform known to spark insightful conversations and inspire through instructional case studies\, out-of-industry perspectives\, and leading-edge technology\, providing attendees with strategies and tactics to grow as leaders\, embrace disruption\, and seize innovation. \nTo learn more about this event\, and to register online\, visit www.epharmasummit.com
URL:https://www.pharmajournalist.com/event/epharma/
LOCATION:New York Marriott Marquis
ORGANIZER;CN="Knect365%2C a division of Informa":MAILTO:frances.pratt@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180323
DTSTAMP:20260515T052604
CREATED:20171031T052535Z
LAST-MODIFIED:20171031T052710Z
UID:3711-1521590400-1521763199@www.pharmajournalist.com
SUMMARY:15th annual Controlled Release Delivery
DESCRIPTION:Building on the success of previous events\, SMi’s Controlled Release Delivery conference returns for its 15th year in London on 21-22 March 2018. \nAs physicians and scientists continue to find strategies to assist in simplifying treatment schedules for patients\, a pharma focus continues to move towards innovative controlled release technologies to improve drug transport to target. \nMoreover\, with the global oral controlled release drug delivery technology market expected to flourish in the next few years\, now is the time to get ahead of the game by exploring and understanding innovations in oral-lipid based and abuse deterrent formulations\, nanoparticles and nanotechnologies\, taste-masking and controlled release approaches\, 3D printed dosage forms and functional film coats. \nFeaturing presentations to analyse and evaluate latest advancements in drug delivery\, this year’s event highlights include: \n\nFormulation of Controlled Release Delivery Technologies and improving the design of new controlled release delivery systems\nInnovative additions to Oral Controlled Release Delivery Technologies\, to improve the pharmacokinetic-pharmacodynamic properties of the drug\nLatest regulation guidance and their implications for the pharmaceutical industry\nClinical developments and lessons learnt during clinical trials\, through case studies with top pharmaceutical companies\n\nFeatured speakers include senior decision makers and innovators from University of Strathclyde\, GSK\, Ipsen\, PLIVA\, SiTech Pharmabio\, Grunenthal\, Colorcon\, Bial\, Peptigel Design\, University of Central Lancashire and more! \nVisit www.controlledreleasedelivery.com/pharmajournalist to view the full list of speakers and their presentations. \nEARLY BIRD : Book by 30 November to save £400. Book by 15 December to save £200. Book by 31st January to save £100.
URL:https://www.pharmajournalist.com/event/15th-annual-controlled-release-delivery/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:hdegracia@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180321
DTEND;VALUE=DATE:20180323
DTSTAMP:20260515T052604
CREATED:20171019T103727Z
LAST-MODIFIED:20171019T103727Z
UID:3505-1521590400-1521763199@www.pharmajournalist.com
SUMMARY:Drug Discovery 
DESCRIPTION:SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March. \n \nThe pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely\, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently\, the event will focus on key developments in this very industry. \nSMi’s 2nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery\, CRISPR and PROTAC’s\, as well as discussing advancements in medicinal chemistry\, translational medicine and 3D structure based-discovery. \nWith huge interest from leaders in the field\, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Drug Discovery yet. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers: \n– Chairman – Darren Green\, Director of Computational Chemistry and Informatics\, GlaxoSmithKline plc\n– Chairman – Guido Hanauer\, CEO\, GHPC GmbH\n– Steve Rees\, Vice-President\, Screening Sciences and Sample Management at AstraZeneca\, Astra Zeneca Plc\n– Claus Bendtsen\, Executive Director/Sr Leader Data Science\, AstraZeneca\n– Ralph Minter\, Director\, Fellow\, Antibody Discovery and Protein Engineering\, MedImmune\n– Stevan Djuric\, Vice President\, AbbVie\n– John Harling\, Director of Chemistry for the Protein Degradation DPU\, GlaxoSmithKline plc\n– Ursula Egner\, Director Process Simulation and Design Collaboration\, Bayer HealthCare \nEarly bird discounts! \n\nRegister by the 30th November to save £400\n15th December to save £200\n31st January to save £100
URL:https://www.pharmajournalist.com/event/drug-discovery/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:nboumediene@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180320
DTEND;VALUE=DATE:20180322
DTSTAMP:20260515T052604
CREATED:20171214T080104Z
LAST-MODIFIED:20171214T080104Z
UID:5339-1521504000-1521676799@www.pharmajournalist.com
SUMMARY:PHARMA SECURITY WORLD 2018
DESCRIPTION:The Counterfeit medicines are turning into a serious concern around the world\, and have progressively been showing up through the real pharmaceutical supply chain\, including community and online drug stores. What’s more\, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue\, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security World 2018 – An Anti-counterfeiting & Brand Safety Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2o5HD1M
URL:https://www.pharmajournalist.com/event/pharma-security-world-2018/
LOCATION:London\, UK
ORGANIZER;CN="Corvus Global Events Limited":MAILTO:info@corvusglobalevents.com/ fazmina@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180320
DTEND;VALUE=DATE:20180322
DTSTAMP:20260515T052604
CREATED:20171204T074612Z
LAST-MODIFIED:20171204T074612Z
UID:4963-1521504000-1521676799@www.pharmajournalist.com
SUMMARY:7th Annual Clinical Data Integration & Management
DESCRIPTION:After the most successful Clinical Data Integration & Management conference to date\, we are excited to announce Arena International will be returning to Princeton in March 2018 for another epic event. \n \nThis year we brought together over 100 senior level professionals working within clinical data management to network and overcome some of the biggest challenges facing the industry. \nA highlight of our 2017 programme included an interactive panel discussion on the first day\, exploring how to achieve the right balance between increasing the data delivery speed whilst continuing to produce high quality data. Attendees had the opportunity to ask our 3 industry experts probing questions to uncover potential solutions to this challenge. \nDay 2 saw an engaging presentation from Johnson & Johnson\, addressing the wearable technologies currently being incorporated into clinical trials. They highlighted various examples of wearables as well as recognizing the challenges with moving towards these advanced technologies. This presentation was followed by a Q&A\, opening up the discussion to the audience. \nNext year’s ECDM event will be even better with more interactive sessions and content. We look forward to seeing you in Princeton next March! \nTo learn more about this event\, and to register online\, visit www.arena-international.com/ecdm/
URL:https://www.pharmajournalist.com/event/7th-annual-clinical-data-integration-management/
LOCATION:Princeton\,NJ
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20260515T052604
CREATED:20171031T010129Z
LAST-MODIFIED:20171031T044056Z
UID:3637-1521417600-1521590399@www.pharmajournalist.com
SUMMARY:12th annual Paediatric Clinical
DESCRIPTION:SMi is pleased to present the return of their 12th annual Paediatric Clinical Trials Conference taking place on 19th – 20th March 2018\, London\, UK. \n \nClinical trials in paediatric populations still pose several challenges and often many studies remain un- published. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno-oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines. \nJoin us as we discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. leading industry experts will be looking at how to work within regulations and foster the involvement of young people in their care. We will also be looking at the planning and executing a paediatric clinical trial and the ways this can vary according to region. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints. \nReasons to attend Paediatric Clinical Trials 2018 \n– Regulatory keynote from the MHRA – The UK’s Early Access to Medicines Scheme (EAMS) and how this scheme benefits paediatric patients\n– Hear from Amgen and Roche as they give exclusive case studies on new approaches to recruitment\, retention\, and clinical trial design for rare diseases\n– Pfizer and Barcelona Children’s Hospital will be exploring how advancements in technology are facilitating improved clinical trials and data collection for paediatric drug development\n– AstraZeneca will be reviewing and discussing paediatric clinical trial Legislation in the EU and US.\n– There will be an exciting panel with the likes of GSK\, Roche and regulatory bodies debating challenges and opportunities 10 years on from paediatric regulation in the EU and potential changes on the horizon\n– There will be multiple pharmaceutical companies (UCB\, Sanofi and GSK) debating scenarios where data extrapolation and government incentives might increase access to medicines in paediatric populations.\n– Discover how to optimise your approach to clinical success through global collaboration being discussed by Takeda
URL:https://www.pharmajournalist.com/event/12th-annual-paediatric-clinical/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:kwilliams@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20260515T052604
CREATED:20171023T082959Z
LAST-MODIFIED:20171023T084059Z
UID:3576-1521417600-1521590399@www.pharmajournalist.com
SUMMARY:20th Annual Superbugs & Superdrugs
DESCRIPTION:Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities\, SMi presents the 20th annual Superbugs &Superdrugs conference which will return to Central London on 19th and 20th March 2018. \nThe threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders\, drug discovery specialists and government bodies such as MHRA and DNDi. \nFEATURED SPEAKERS INCLUDE: \n– Richard Bax\, Senior Partner\, TranScrip Partners\n– Lloyd Czaplewski\, Director\, Chemical Biology Ventures\n– Mair Powell\, Senior clinical assessor\, MHRA\n– Jean-Pierre Paccaud\, Director of Business Development at GARDP\, Drugs for Neglected Diseases initiative (DNDi)\n– Conrad Lichtenstein\, CSO\, Nemesis bioscience\n– David Brown\, Managing Director and Founder\, Alchemy Biomedical Consulting\n– Domingo Gargallo-Viola\, Chief Scientific Officer\, ABAC Therapeutics\n– John George\, CSO\, Oppilotech\n– Larry Sutton\, Scientific Founder\, Gladius Pharmaceuticals\n– Kathy Talkington\, Project Director\, Pew charitable trusts\n– David Cook\, Chief Scientific Officer\, Blueberry Therapeutics\n– William Weiss\, Director of Pre-Clinical Services\, University of North Texas Health Science Center\n– Cara Cassino\, Chief Medical Officer\, ContraFect\n– Stephen Barat\, Head of Pre-Clinical and Early Clinical Development\, SCYNEXIS Inc \nWHATS ON THE AGENDA FOR 2018? \n– Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR\n– Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress\n– Learn about regulatory pathways for the registration of new antimicrobial agents\n– Evaluate the latest incentives and funding solutions to spur drug discovery\n– Explore novel alternatives to antibiotics currently in development \nTo register visit www.superbugssuperdrugs.com/pjournalist \nFor enquires contact the team on +44 (0)207 827 6000 or email events@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/20th-annual-superbugs-superdrugs/
LOCATION:Copthorne Tara Hotel\, Kensington\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180314
DTEND;VALUE=DATE:20180316
DTSTAMP:20260515T052604
CREATED:20171108T071214Z
LAST-MODIFIED:20171108T071236Z
UID:3865-1520985600-1521158399@www.pharmajournalist.com
SUMMARY:Temperature Maintenance of Biopharmaceuticals in Distribution 2018
DESCRIPTION:After an incredibly successful Temperature Maintenance of Biopharmaceuticals in Distribution event\, we are excited to announce the event programme for this year’s event! \nOur 2017 programme provided a holistic approach to temperature controlled shipments whilst also addressing transportation obstacles and regulatory compliance. Topics included transportation\, GDP compliance\, qualification systems and case studies from both cold chain and ambient product perspectives. \nWhether you are from a small biotech or a large pharma company this event is the perfect platform to share challenges\, network with over 400 industry peers and hear informative case studies. \n2018 Key Speakers: \n– Chris Wallace\, Senior Director\, International Supply Chain Operations\, Genzyme\n– Clemens Twardy\, Head of Logistics\, Boehringer Ingelheim\n– Francisco Rizzuto\, Cargo Specialist\, IATA\n– Sven Sachsse\, Transport Expert – Supplier Qualification\, Bayer\n– Nicola Caristo\, Pharma Audit and Compliance Manager\, ALHA Group\n– Marc Sotty\, Studies and Distribution Head\, Sanofi \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/pharmatemp
URL:https://www.pharmajournalist.com/event/temperature-maintenance-biopharmaceuticals-distribution-2018/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International Events Group":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180314
DTEND;VALUE=DATE:20180316
DTSTAMP:20260515T052604
CREATED:20171108T070708Z
LAST-MODIFIED:20171108T070708Z
UID:3860-1520985600-1521158399@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Europe 2018
DESCRIPTION:CTS Europe will be returning for the 19th edition next March. This prestigious event will welcome   representatives from 6 of the top 10 pharmaceutical companies in Europe\, who will be joined by leading biotech companies across the continent to jointly find solutions for your clinical trial supply problems and discuss changes in the industry. \nAs a streamed event this conference promises to address a larger variety of topics\, with sessions covering all the essentials in clinical supply\, from maximising forecasting software to patient centric strategies for supply chain and considering methods to achieve last mile delivery. \n2018 Key Speakers: \n– Jan-Pieter Kappelle\, Senior Director\, Clinical Trial Supplies\, UCB\n– Henk Mollee\, Senior Director\, CTM Manufacturing\, Astellas Pharmaceuticals\n– Niklas Mattsson\, Lead Comparator Sourcing and Planning\, MSD\n– Alison Meyers\, Director Clinical Liaison Lead\, Clinical Interface\, GlaxoSmithKline\n– Ross MacRae\, Senior Director Clinical Manufacturing\, Pfizer\n– Erik Meyer\, Director Clinical Trial Supply\, Merck\n– Peter Orosz\, Head of Clinical Supply Chain Management & Oncology\, Boehringer Ingelheim\n– Alex Robertson\, Senior Director\, Supply Chain Management\, AstraZeneca \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/ctseurope
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-europe-2018/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International Events Group":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260515T052604
CREATED:20180103T025327Z
LAST-MODIFIED:20180103T025445Z
UID:6477-1520899200-1521071999@www.pharmajournalist.com
SUMMARY:Pharmaceutical Compliance Congress (PCC) Asia
DESCRIPTION:Uncover the Risks Associated with Anti-Bribery and Anti-Corruption\, Data Privacy and HCP Engagement\n \nBacked by 20 years of global compliance programming and education\, CBI’s Pharmaceutical Compliance Congress (PCC) Asia is the premier event for compliance teams to gain novel approaches and advanced strategies for the quickly transforming regulatory landscape. \nWith rapidly evolving global regulations deeply affecting business operations in Asia\, multi-national life sciences companies must be more attentive than ever. Increasing anti-bribery and anti-corruption requirements from the U.S.\, UK and local Asian regulatory bodies are driving compliance professionals to build and maintain effective compliance programs that not only meet these multi-jurisdictional requirements\, but align with their overall business objectives. \nThis fully-packed two day forum features in-depth content and insights around the most important compliance and legal issues in China\, South Korea\, Japan\, Indonesia\, India\, Thailand\, Vietnam\, Malaysia\, the Philippines and Australia. Join the brightest minds and most influential stakeholders in life sciences compliance to benchmark\, exchange strategies and learn about the latest guidance and laws\, surrounding bribery and corruption\, HCP engagement\, transparency\, data privacy\, competition\, intellectual property and more. \nTo learn more about this event\, and to register online\, visit www.cbinet.com/PCCAsia
URL:https://www.pharmajournalist.com/event/pharmaceutical-compliance-congress-pcc-asia/
LOCATION:Grand Hyatt Shanghai\, Jin Mao Tower 88 Century Avenue\, Pudong\, Shanghai\, 200121\, China
ORGANIZER;CN="CBI%2C a division of UBM Americas":MAILTO:cbireg@cbinet.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260515T052604
CREATED:20171213T031929Z
LAST-MODIFIED:20171213T031929Z
UID:5302-1520899200-1521071999@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials Southeast
DESCRIPTION:For the 7th Outsourcing in Clinical Trials conference we will once again be welcoming a number of senior industry peers who given their experience will present\, debate and drive the conversation over our two day event. In 2018 you will be given the opportunity to delve straight into the big hot topics facing your outsourcing and operational challenges with regards to clinical trials and be prepared to address the changes facing the industry\, ensuing you are fully equipped for the future. \nSome hot topics highlights which we will be addressing at next year’s event are: \n– Uncovering ways through which you can manage your vendors without duplicating tasks\, affecting trial integrity and increasing in-house responsibilities \n– Improving staff recruitment; discussing how industry and academia can work together to ensure adequate training for future clinical trial staff to ensure trials are not compromised \n– To outsource or not to outsource\, this is the question? Examining the arguments behind keeping capabilities in house versus contracting out \n– Approaching funding opportunities strategically; which funding options are available for small-midsize pharma and biotech to boost your pipeline \nThese sessions will endeavour not only to answer questions\, but to open the floor to discussion so that sponsors and vendors alike can interact with one another and discover ways through which relationships and expectations can be best managed. With panel discussions\, debates and presentations\, this year’s program is certain to provide a platform for each and every delegate to explore the challenges affecting them and what feasible solutions could be adopted to solve these.
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-southeast/
LOCATION:Durham\, North Carolina
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180312
DTEND;VALUE=DATE:20180314
DTSTAMP:20260515T052604
CREATED:20171106T102949Z
LAST-MODIFIED:20171107T021556Z
UID:3811-1520812800-1520985599@www.pharmajournalist.com
SUMMARY:2nd Digital Pharma Multichannel Marketing Boot Camp West
DESCRIPTION:The 2nd Digital Pharma Multichannel Marketing Boot Camp West uses a combination of lectures\, class discussions and hands-on exercises with people who want to understand how to create effective and sophisticated digital and multichannel marketing (MCM) strategies. This intensive\, two-day program not only teaches you strategic processes\, it also gives you the tools and skills you need to gather insights and develop your own digital and multichannel programs. \nTo learn more about this event\, and to register online\, visit http://digitalpharmaseries.com/bootcamp \n 
URL:https://www.pharmajournalist.com/event/2nd-digital-pharma-multichannel-marketing-boot-camp-west/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Boulevard\, Burlingame\, CA\, 94010\, United States
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180307
DTEND;VALUE=DATE:20180309
DTSTAMP:20260515T052604
CREATED:20171212T070945Z
LAST-MODIFIED:20171212T070945Z
UID:5264-1520380800-1520553599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England
DESCRIPTION:The 7th Annual Clinical Trial Supply New England is back in 2018 on the 7th-8th March for what promises to be a fantastic event. The perfect event for all biotech’s and pharma companies in the New England region to come together and explore the latest issues\, trends and technologies within the clinical supply world. \nUnderstanding the characteristics of the region\, we have created a two days conference with full of sessions that will be an interest of smaller pharma and biotechs. It is all geared up with fresh up-to-date topics that you can learn from how your peers in the industry are managing the challenges and seek for new strategies from thought-provoking discussions. \nHere is the preview of two key topics for the 2017 event. \nImport and export regulation \nNo one likes getting unexpected bills. So do you. Marco Afonso\, Supervisory Import Specialist at U.S. Customs and Border Protection will be presenting a detailed exploration the evolving landscape of importing clinical trial materials and products into the US specifically investigating the key facts all companies should know when importing to the US to clarify your obligations to tax\, VAT and regulatory transgressions. \nContingency planning for natural disasters \nAs climate change worsens and typical weather patterns are altered resulting in unforeseen natural phenomena it is paramount of the industry to be able to react in a quick\, seamless manager when typical supply chain routes are disrupted. Chad Presher\, Associate Director\, Clinical Drug Supply\, Biogen will be presenting a case study which will among other things\, focus on the implications of hurricane Harvey on clinical trials to better prepare responses to ensure trial supply reaches the site
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180221
DTEND;VALUE=DATE:20180223
DTSTAMP:20260515T052604
CREATED:20171023T075622Z
LAST-MODIFIED:20171023T084319Z
UID:3564-1519171200-1519343999@www.pharmajournalist.com
SUMMARY:3D Cell Culture 2018
DESCRIPTION:Building on the sell-out success of the launch event\, SMi Group is delighted to announce the return of 3D Cell Culture\, taking place on 21st and 22nd of February 2018\, in London UK. \n3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields\, such as 3D bioprinting and microfluidics. \nThe 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models\, organoids\, organ-on-a-chip technologies\, iPSC advances plus much more!  \nFEATURED SPEAKERS: \n– Gary Allenby\, Business Development Director and Chief Scientific Officer\, Aurelia Bioscience\n– Mr Stefan Przyborski\, Scientific Founder\, ReInnervate Limited\n– Mr Ricardo Baptista\, Lead Scientist Process Development\, Cell and Gene Therapy Catapult\n– Dr Nicholas Leslie\, Tumour Biologist\, Heriot-Watt University\n– Dr SuwanJaysinghe\, Professor of Bioengineering\, University College London\n– Dr Max Salick\, Postdoctoral Researcher\, Novartis Institutes for Biomedical Research\n– Dr Patrick Kugelmeier\, Director of Science\, Kugelmeiers\n– Dr Vitor Santo\, Senior Scientist\, Immunocore\n– Mr Christopher Schofield\, Investigator\, GSK\n– Mr David Pan\, Programme Manager (Regenerative Medicine)\, UK Regenerative Medicine Platform\n– Dr Reyk Horland\, Head of Business Development\, TissUse GmbH \nREASONS TO ATTEND IN 2018\n \n– Uncover the biology of human neurodevelopment diseases in 3D by merging cutting edge technologies in CRISPR editing and single cell sequencing\n– Take a 3D biology approach to overcome challenges for well based screening with exclusive insight into electrospun micro-scaffold based biology\n– Develop strategies for optimising placement of cells in printing by identifying key developments in the overlap of 3D bioprinting and 3D cell culturing\n– Discover new approaches to predictive substance testing through innovative case study insight into multi-organ-chip technology\n– Benefit from an agenda tailored towards driving clinical development through ground breaking case studies on the Zika virus and tuberous sclerosis \n2017 ATTENDEE TESTIMONIALS \n“Very good presentations and a few outstanding ones… I made some useful contacts” ASTERAND BIOSCIENCE \n“The conference was wonderfully organised” NOVARTIS \n“Good start\, love to see the event occur again” THERMO FISHER SCIENTIFIC \n\nFor further details visit http://www.3D-CellCulture.com/pjournalist or contact the team on +44 (0)20 7827 6000
URL:https://www.pharmajournalist.com/event/3d-cell-culture-2018/
LOCATION:Holiday Inn Kensington Forum\, London UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180221
DTEND;VALUE=DATE:20180223
DTSTAMP:20260515T052604
CREATED:20171011T060348Z
LAST-MODIFIED:20171011T060745Z
UID:3391-1519171200-1519343999@www.pharmajournalist.com
SUMMARY:10th Annual Pharma Packaging and Labeling East Coast Conference
DESCRIPTION:The 10th Annual Pharma Packaging and Labeling East Coast event aims to create an environment where commercial packaging and labeling teams work together to successfully manage both creative and regulatory demands while safeguarding products and protecting patients. To achieve this we have brought together top industry leaders whose experience will enable you to make this a reality. \nThis year we will be exploring topics which affect both commercial labelling and packaging teams across small\, medium and large pharma. We will have a co-presentation looking at the industries end-to-end labeling strategy to ensure companies are inspection ready while harnessing branding as a story telling the tool to remain relevant to your consumers\, old and new. Coupled with this we aim to show ways through which the operational challenges of serialization can be overcome and improved to ensure you are meeting compliance standards. We are also happy to announce that the Drug Enforcement Administration will be returning\, offering an opportunity to hear a different perspective on ways that pharma can serve the public health. \nTo learn more about this event\, and to register online\, visit https://goo.gl/3HhKjN
URL:https://www.pharmajournalist.com/event/10th-annual-pharma-packaging-labeling-east-coast-conference/
LOCATION:Philadelphia\, USA\, TBA
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180206
DTEND;VALUE=DATE:20180208
DTSTAMP:20260515T052604
CREATED:20171031T005520Z
LAST-MODIFIED:20171031T005651Z
UID:3633-1517875200-1518047999@www.pharmajournalist.com
SUMMARY:12th annual Parallel Trade
DESCRIPTION:SMi Group is proud to announce the return of Europe’s only Parallel Trade conference. Back for the 12th year\, Parallel Trade returns to London on 6th-7th February 2018. \n \nOver the years\, the European Single market has allowed for pharmaceuticals to be imported and exported freely between member states without the permission of the manufacturers. However\, with the arrival of Brexit and guidelines to immanently enforce the Falsified Medicines Directive (FMD) by 2019\, the market for pharmaceutical parallel trade is changing. \nJoin us as we discuss the latest changes to regulation\, their implementation and major court cases in intellectual property influencing distribution practices. We will also be exploring the safety of patients in relation to the surge in pharmaceutical E-commerce and ways in which currency fluctuations are likely to disrupt the flow of drugs to certain countries in the EU and beyond. \nWith huge interest from leaders in the field\, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Parallel Trade event. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers \nParallel Trade 2018 will cover the important issues of:\n \n– Maintaining the integrity of the supply chain\n– Addressing recent developments concerning intellectual property and regulatory law\n– Forecasting currency fluctuations across the single market and the affect this might have on drug shortages\, prices and patient accessibility\n– Exploring how Brexit will impact pharmaceutical trade and\n– market access in Europe\n– Providing an insight into current anti-trust investigations from industry leaders and the consequences this could have on pharmaceutical parallel trade
URL:https://www.pharmajournalist.com/event/12th-annual-parallel-trade/
LOCATION:Holiday Inn Kensington Forum\, London UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:kwilliams@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180205
DTEND;VALUE=DATE:20180208
DTSTAMP:20260515T052604
CREATED:20171121T064101Z
LAST-MODIFIED:20171121T064454Z
UID:4351-1517788800-1518047999@www.pharmajournalist.com
SUMMARY:3rd annual North American Microbiome Congress
DESCRIPTION:The 3rd Annual North America Microbiome Congress in San Diego\, by Kisaco Research\, has become a trusted learning and networking platform and a true business community for microbiologists\, clinicians regulatory and industry executives who require an insight into the latest microbiome research\, clinical trials and collaborative partnerships. \nWith a focus on 5 microbiome niches such as the gut\, lung\, oral\, skin and vaginal- we invite you to join us for 3 days of intense learning\, mind-sharing and networking opportunities designed to encourage meaningful connections. In addition\, we will be hosting poster sessions for PhD students to provide opportunities for all scientists to learn about state-of-the-art research methods and clinical protocols for conducting microbiome work. \n– Meet and learn from industry leaders\n– Consider the practical aspects of promoting effective partnerships\n– Learn from the latest unpublished data\n– Network with top academics and clinicians in the field
URL:https://www.pharmajournalist.com/event/3rd-annual-north-american-microbiome-congress/
LOCATION:The Hilton San Diego Resort & Spa\, 1775 East Mission Bay Drive\, San Diego\, CA\, 92109\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180130
DTEND;VALUE=DATE:20180201
DTSTAMP:20260515T052604
CREATED:20171013T002500Z
LAST-MODIFIED:20171013T003516Z
UID:3441-1517270400-1517443199@www.pharmajournalist.com
SUMMARY:LEAP HR: Life Sciences: West Coast Edition
DESCRIPTION:Step Inside the Innovative People Strategies Helping the Most Dynamic Life Sciences Firms Break Through in a Hyper-Competitive Industry \nThis West Coast edition of LEAP HR: Life Sciences offers you the chance to step inside the people strategies helping the most innovative biopharma businesses build a scalable culture of innovation during rapid growth. \nIt shines a light on how you can transform HR impact in a fast-moving industry\, manage the people implications of growth\, and rethink engagement\, retention and rewards in a hyper-competitive industry. \nThis is a high-energy\, high impact\, fully-immersive experience. It’s the place for ambitious people leaders to engage in a disruptive dialogue around how to deal with the implications of working in a fast-paced\, hyper-competitive\, science-centric industry. Take this opportunity to explore truly transformative strategies to revolutionize HR impact. \nTo learn more about this event\, and to register online\, visit http://bit.ly/leaphrlifesciences
URL:https://www.pharmajournalist.com/event/leap-hr-life-sciences-west-coast-edition/
LOCATION:The Marker 501 Geary Street\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@leap-hr.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180129
DTEND;VALUE=DATE:20180202
DTSTAMP:20260515T052604
CREATED:20170919T071927Z
LAST-MODIFIED:20170919T073104Z
UID:3147-1517184000-1517529599@www.pharmajournalist.com
SUMMARY:Temperature Controlled Logistics 2018
DESCRIPTION:In planning the 2018 Temperature Controlled Logistics conference\, Pharma IQ surveyed over 50 senior supply chain and logistics experts from big and small pharmaceutical companies\, as well as from consumer industries. The main question they were looking to answer was: what is the main factor that defines a cost effective\, secure\, and GDP compliant temperature controlled supply chain that experiences minimal temperature excursions? The overarching answer was clear: planning. Strengthen your end-to-end supply chain planning\, and your temperature controlled logistics will be easier\, cheaper\, and better. \n  \nIn recognition of this\, TCL 2018\, takes you on a journey from the beginning of your supply chain\, to the very end. The three separate streams will look at: \n-> Pre-Transportation – with sessions such as “Enabling End-to-End Supply Chain Planning\, Visibility\, and Decision Making through Standardisation & IT Integration Across Global Sites” (Merck) and “Optimising Lane Qualification with all Supply Chain Stakeholders in Challenging Shipping Environments” (Bayer) \n-> Transportation – with sessions such as “A Global Approach to Reducing Temperature Excursions” (Genzyme) and “Maintaining Temperature Control in the World’s Most Challenging Situations” (Médecins Sans Frontières) \n-> Last Mile and Post-Distribution – with sessions such as “Last Mile Distribution – The Final Stage of End-to-End Temperature Monitoring (EZR Group) and “Working with Partners to Close Gaps in the Last Mile” (Novartis) \nThe goal of the event  is for each and every delegate who attends TCL 2018 to leave understanding what best practice planning and execution looks like at every stage of their temperature controlled supply chain. With over 50 case studies from pharmaceutical manufactures and regulatory bodies that address key operational and strategic considerations\, bring your team to ensure coverage of all relevant sessions. \nThe  world famous exhibition will\, as per tradition\, run parallel to the conference\, so that you have the chance to identify solution providers who can support the implementation of new solutions and strategies. In a brand new location of Twickenham Stadium\, the big red London bus won’t be joining this year\, but they have plenty of new surprises that await!  Don’t to miss the BRAND NEW Sea Freight Focus Day! Details on the agenda at https://www.temperaturecontrolledlogistics.com/ \nThe early bird special has just kicked off\, and there are a few ways to capitalise on these discounts:\n1. Online here: https://www.temperaturecontrolledlogistics.com/\n2. Email: enquire@iqpc.co.uk\n3. Telephone +44 (0) 20 7036 1300
URL:https://www.pharmajournalist.com/event/temperature-controlled-logistics-2018/
LOCATION:Twickenham Stadium\, London
ORGANIZER;CN="IQPC":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180117
DTEND;VALUE=DATE:20180119
DTSTAMP:20260515T052604
CREATED:20170908T053845Z
LAST-MODIFIED:20170908T054719Z
UID:3027-1516147200-1516319999@www.pharmajournalist.com
SUMMARY:10th Annual Pre-filled Syringes Europe
DESCRIPTION:Join the calendar event highlight for the medical device industry at Europe’s leading 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a perfect platform to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and booming market. \n \nWhat will the future of the pharmaceutical industry look like following an increase in the number of generics and biosimilars hitting the market; a trend in the rise of self-administered drugs and personalised medicine; and Britain’s recent decision to leave Europe? How will these changes affect the PFS industry? \nBuilding on the success of its sell-out global 2017 PFS series of events which saw 100+ attendees join shows in London\, Boston and San Diego\, the agenda for Pre-Filled Syringes Europe 2018 has been carefully tailored to arm you with the key requirements and tools to adapt to an ever-changing medical landscape in areas that are critical to those working within parenteral drug delivery and injectable devices. \nFeatured Speakers: \n– AlphonsFakler\, Group Head Risk Management\, Novartis Pharma\n– BettineBoltres\, Technical Account Manager\, West Pharmaceutical Services\n– Elizabeth Baker\, Group Manager Licensing Division\, MHRA\n– Marcel Mueller\, Device Project Leader\, Novartis\n– Cedric Gysel\, Staff Device Engineer\, Janssen\n– Carsten Worsoe\, Principal Scientist\, CMC Analytical Support\, Novo Nordisk\n– VikasJaitely\, Senior Manager CMC Regulatory Intelligence and Pharmaceutical Science\, Merck\n– Susanne Joerg\, Head of Formulation Development\, Lonza\n– Orla Downes\, Head of Business Development Unit\, Barts Health Pharmaceuticals\n– Barry Knight\, Device Program Lead\, UCB Celltech\n– Sudeshna Dutta Ray\, Senior Engineer\, Advanced Device Technology and Innovation\, Amgen\n– Alexander Jung\, Senior Manager\, Technology and Innovation\, Drug Delivery and Devices\, Boehringer Ingelheim\n– Christian Dechant\, Primary Packaging Director\, Boehringer Ingelheim \nTo learn more about this event\, and to register online\, visit https://goo.gl/xiHQvu  \n 
URL:https://www.pharmajournalist.com/event/10th-annual-pre-filled-syringes-europe/
LOCATION:Copthorne Tara Hotel\, London UK
ORGANIZER;CN="SMI Group Ltd":MAILTO:tarri@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171206
DTEND;VALUE=DATE:20171208
DTSTAMP:20260515T052604
CREATED:20170925T092900Z
LAST-MODIFIED:20170925T092900Z
UID:3237-1512518400-1512691199@www.pharmajournalist.com
SUMMARY:3rd Annual Clinical Trial Supply (CTS) East Asia
DESCRIPTION:This event has now reached its third birthday and is fast becoming an industry must attend show. Since 2015 the event is forecast to almost double in revenue and it’s imperative that the program brings together a mixture of the biggest companies to keep attracting vendors. \nThe delegate campaign has been very successful in both 2015 and 2016\, attracting a large number of attendees from South Korea\, Japan\, China\, Taiwan and Singapore. It’s important that this mix is reflected on the program and that presentations are sought from across East Asia. \n Why CTS East Asia? \nAsia now has more clinical trials than any other region in the world. Through research with suppliers there is some disagreement over whether the local market is growing in terms of companies\, however no dispute at all in the number of trials happening in the region. \nTo learn more about this event\, and to register online\, visit https://goo.gl/UdMMN7
URL:https://www.pharmajournalist.com/event/3rd-annual-clinical-trial-supply-cts-east-asia/
LOCATION:Seoul\, South Korea
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171206
DTEND;VALUE=DATE:20171208
DTSTAMP:20260515T052604
CREATED:20170922T053049Z
LAST-MODIFIED:20170925T092546Z
UID:3194-1512518400-1512691199@www.pharmajournalist.com
SUMMARY:2nd Outsourcing in clinical trials (OCT) East Asia
DESCRIPTION:The aim of the event is to offer case studies and insight into how to effectively outsource and manager clinical trials throughout East Asia. The programme incorporates insight from both small and big pharma and sessions will take place in both English and Korean. \nThis year’s event is taking place in Seoul\, (South Korea) where there is a good balance of local and global pharma companies. Korea has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar \nWhy South Korea? \nThe event is taking place in South Korea\, this is because there is a good balance of local and global pharma companies. Korea also has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar. \nTo learn more about this event\, and to register online\, visit https://goo.gl/cGi5Qy
URL:https://www.pharmajournalist.com/event/2nd-outsourcing-clinical-trials-oct-east-asia/
LOCATION:Seoul\, South Korea
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
END:VCALENDAR